About 300 reports

  • filgrastim
  • Neupogen| filgrastim - clinical trials (Year-wise)

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by 2015 sales) used in the treatment of chemotherapy-induced febrile neutropenia. These drugs, both belonging to biotech giant Amgen, fall under...

  • Drug Discovery And Development
  • United States
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Neupogen group

In 2015, Sandoz received FDA approval for Zarxio, a biosimilar version of filgrastim for all the same indications as branded filgrastim.

  • Drug Discovery And Development
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Clinical Trial profile. 278 Trial Title
  • Clinical Trial profile. 236 Trial Title

Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, H2, 2017" provides an overview of Leukocyte Disorders (White Blood Cell Disorders)...

  • Blood Disease
  • Chemotherapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • PROMINENT DRUGS
  • Clinical Trial profile. 341 Trial Title

Neutropenia Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Neutropenia Global Clinical Trials Review, H1, 2018" provides an overview of Neutropenia clinical trials scenario.This report provides top line data relating to the clinical trials on Neutropenia. Report...

  • Blood Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Therapy
  • World
  • Clinical Trial profile. 7 Trial Title
  • Clinical Trial profile. 140 Trial Title

Hematological Tumor Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2017" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Hematological...

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Clinical Trial profile. 59 Trial Title

One anti-drug antibody was observed for ALXN## and one for Soliris.

  • Drug Discovery And Development
  • Leukemia
  • World
  • Product Initiative
  • Alexion Pharmaceuticals, Inc.
  • Clinical Trial profile. 33 Trial Title
  • Clinical Trial profile. 118 Trial Title

Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Clinical Trial profile. 208 Trial Title
  • Clinical Trial profile. 173 Trial Title

Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Myelodysplastic Syndrome clinical trials scenario.This report provides top line data relating to...

  • Drug Discovery And Development
  • Leukemia
  • Monoclonal Antibody
  • United States
  • World
  • Clinical Trial profile. 49 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Kaposi Sarcoma Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Kaposi Sarcoma Global Clinical Trials Review, H2, 2017" provides an overview of Kaposi Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Kaposi...

  • Clinical Trial
  • Drug Discovery And Development
  • Targeted Therapy
  • World
  • Product Initiative

Consequent to the approval of Novartis' Filgrastim biosimilar in the US-the first biosimilar to receive FDA approval-it is expected that the focus on biosimilars will increase in the country.

  • Drug Discovery And Development
  • North America
  • United States
  • World
  • Horizon Discovery
  • Clinical Trial profile. 153 Trial Title
  • PROMINENT DRUGS

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## pegfilgrastim alone or in combination has the highest number of febrile neutropenia ongoing clinical trials.

  • Chemotherapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Clinical Trial profile. 18 Trial Title
  • Clinical Trial profile. 194 Trial Title

Monday, April ##, ##:##-##:## p. m.

  • Clinical Trial
  • Drug Discovery And Development
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 1220 Trial Title
  • Clinical Trial profile. 1719 Trial Title

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H1, 2018" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario.This report provides...

  • Clinical Trial
  • Drug Discovery And Development
  • Oncology
  • World
  • Celgene Corporation
  • NAME

s Zarxio (filgrastim-sndz), in the U. S.

  • Clinical Research
  • Drug Discovery And Development
  • North America
  • United States
  • World
  • Clinical Trial profile. 181 Trial Title
  • Clinical Trial profile. 34 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Progenics Pharmaceuticals Inc ## ## ## ## ## ## ## ## United Therapeutics Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## APEIRON Biologics AG ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Y-mAbs Therapeutics Inc ##

  • Clinical Trial
  • Drug Discovery And Development
  • Oncology
  • World
  • Progenics Pharmaceuticals, Inc.
  • Clinical Trial profile. 140 Trial Title
  • Clinical Trial profile. 422 Trial Title

Brain Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview...

  • Drug Discovery And Development
  • Oncology
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 161 Trial Title

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Canada Source: GlobalData' s Phar

  • Blood Disease
  • Drug Discovery And Development
  • General Medicine And Specialty Medicine
  • World
  • Product Initiative

The FDA requires that the biosimilar INN is followed by a four letter suffix, denoting the product manufacturer name, such as filgrastim-sndz in the case of the filgrastim TABLE ##: TRASTUZUMAB BIOSIMILARS, 2017 ##. ##. ## NOMENCLATURE biosimilar by Sandoz.

  • Drug Discovery And Development
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Clinical Trial profile. 11 Trial Title
  • Clinical Trial profile. 16 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Leukemia
  • Therapy
  • Novartis AG
  • Clinical Trial profile. 59 Trial Title

Ovarian Disease Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Ovarian Disease Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Disease clinical trials scenario.This report provides top line data relating to the clinical trials on Ovarian...

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • Pharmaceutical
  • World

Gland Surgery; ##(##): ##-## Zhang P, et al. (2016).

  • Drug Discovery And Development
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • World
  • Bayer AG

The prominent features of this report are - ##.

  • Clinic
  • Clinical Trial
  • Drug Discovery And Development
  • Therapy
  • Eli Lilly & Co.

Hypertension; ##(##): ## Johnston S, et al. (2016).

  • Drug Discovery And Development
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Clinical Trial profile. 153 Trial Title
  • Clinical Trial profile. 297 Trial Title

Bone Sarcoma Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Bone Sarcoma Global Clinical Trials Review, H1, 2017" provides an overview of Bone Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Sarcoma. Report includes an overview...

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • United States
  • World
  • Clinical Trial profile. 566 Trial Title
  • CLINICAL TRIAL PROFILE. 1884 TRIAL TITLE

Ovarian Cancer Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Cancer clinical trials scenario.This report provides top line data relating to the clinical trials on Ovarian...

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • Ovarian Cancer
  • World
  • Target
  • Clinical Trial profile. 6 Trial Title

Leiomyosarcoma Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Leiomyosarcoma Global Clinical Trials Review, H2, 2017" provides an overview of Leiomyosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Leiomyosarcoma....

  • Clinical Trial
  • Drug Discovery And Development
  • Monoclonal Antibody
  • World
  • Product Initiative
  • AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017*
  • Prominent Drugs

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Neurology
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • Drug Discovery And Development
  • Leukemia
  • Novartis AG
  • Cutaneous B- Cell Lymphoma Pipeline Drug Profiles- Type, Class, Route
  • of Administration, Mechanism of Action, Target (2)

Lymphoma is a cancer type where uncontrollable growth of lymphocytes (WBCs) initiating from lymph glands or lymphatic tissue or other parts of the lymphatic system, including bone marrow, tonsils, testicles, spleen and lymph nodes. This excess growth of lymphocytes often accumulates in lymph nodes. Though this accumulation can occur...

  • Drug Discovery And Development
  • Europe
  • North America
  • World
  • Company Operations